FDA's Push For Compounding Oversight Meets Skepticism

Legal and public health experts are skeptical of the U.S. Food and Drug Administration's push for new authority over compounding pharmacies, arguing the FDA could have used its existing power to...

Already a subscriber? Click here to view full article